HH
Horn Howard
Chief Financial Officer
OtherM
Insider track record
CFOAcross 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Horn Howard, Chief Financial Officer. Insider active across 2 companies, notably Vir Biotechnology, Inc.. Aggregated, 13 reports have been logged. Split: 0 buy · 8 sells. Total volume traded: €1m. History available since 17 February 2022. The latest transaction was disclosed on 1 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations13 total
4,698 shares@ US$33.130.0073% mcap24.3% of flowCommon StockSEC:0001193125-26-296128:0
34,674 shares0Common StockSEC:0001193125-26-164247:0
4,683 shares@ US$20.9713.1% of flowCommon StockSEC:0001193125-26-140702:0
7,942 shares@ US$31.51Common StockSEC:0001193125-25-238708:0
1,785 shares@ US$40.4015.6% of flowCommon StockSEC:0000950170-25-036056:0
15,653 shares0Common StockSEC:0000950170-25-032750:0
7,465 shares@ US$52.7684.4% of flowCommon StockSEC:0000950170-24-114378:0
19,400 shares0Common StockSEC:0000950170-24-026672:0
80,366 shares0Common StockSEC:0001209191-23-052466:0
2,248 shares@ US$25.97330.6% of flowCommon StockSEC:0001209191-23-013007:0
2,424 shares@ US$25.28832.0% of flowCommon StockSEC:0001209191-23-011382:0
35,000 shares0Common StockSEC:0001209191-22-012951:0
2,393 shares@ US$31.93090.0080% mcap100.0% of flowCommon StockSEC:0001209191-22-011735:0
About Horn Howard
Howard Horn is the Chief Financial Officer at Vir Biotechnology, Inc. He oversees the financial operations of the company, including budget planning and financial reporting. His expertise is crucial in ensuring the financial stability and growth of the organization.